Publications

5530 Results

Immunocytochemical analysis of HER-2/neu oncogene expression in in situ and invasive breast carcinoma: evaluation of pathological characteristics and biological significance.

Authors
DC Allred;R Molina;AK Tandon;CK Osborne;DC Tormey;KW Gilchrist;WL McGuire
Journal / Conference
Modern Pathology 3(1):34
Year
1990
Research Committee(s)
Breast
Study Number(s)
SWOG-8696 (INT-0076) (EST-7186)

Optimization of immunocytochemical PGP assessment in multidrug resistant plasma cell myeloma using three antibodies.

Authors
TM Grogan;WS Dalton;JA Rybski;P Meltzer;L Richter;M Gleason;A Cline;RJ Scheper;S Salmon
Journal / Conference
Lab Invest 63:815-824
Year
1990

Survival outcome after Hodgkin's disease: A report from the international data base on Hodgkin's disease

Authors
M Henry-Amar;R Somers
Journal / Conference
Seminars in Oncology 17(6):758-768
Year
1990

Randomized phase III trial of chemoimmunotherapy in patients with previously untreated stages III & IV suboptimal disease ovarian cancer: A Southwest Oncology Group Study.

Authors
DS Alberts;N Mason-Liddel;RV O'Toole;TM Abbott;R Kronmal;RD Hilgers;EA Surwit;HJ Eyre;LH Baker
Journal / Conference
Gyn Onc 32:8-15
Year
1989
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-7925

Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation and maintenance chemotherapy.

Authors
KK Hussein;S Dahlberg;D Head;CC Waddell;L Dabich;JK Weick;F Morrison;JH Saiki;E Metz;SE Rivkin;MR Grever;D Boldt
Journal / Conference
Blood 73(1):57-63
Year
1989
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8001

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma.

Authors
ED Crawford;MA Eisenberger;DG McLeod;JT Spaulding;R Benson;FA Dorr;BA Blumenstein;MA Davis;PJ Goodman
Journal / Conference
N Engl J Med 321:419-424
Year
1989
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8494 (INT-0036)

Combination chemotherapy and high-dose cyclophosphamide intensification for poor prognosis breast cancer. A Southwest Oncology Group Study.

Authors
GK Ellis;S Green;S Schulman;BL Tranum;RS Goldberg;RB Livingston
Journal / Conference
Cancer 64:2409-2415
Year
1989
Research Committee(s)
Breast
Study Number(s)
SWOG-8571

Pathogenetic implications of internuclear bridging in myelodysplastic syndrome. An Eastern Cooperative Oncology Group/Southwest Oncology Group Cooperative Study

Authors
DR Head;K Kopecky;JM Bennett;K Grenier;FS Morrison;KB Miller;MR Grever
Journal / Conference
Cancer 64:2199-2202
Year
1989
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8592

Quality of life end points in cancer clinical trials: Review and Recommendations

Authors
CM Moinpour;P Feigl;B Metch;KA Hayden;FL Meyskens;J Crowley
Journal / Conference
JCO 8(7):485-495
Year
1989

Localized (stage I & II, A & B), hodgkin's disease treated with extended field radiotherapy vs. involved field radiotherapy plus MOPP with 16 year followup: A Southwest Oncology Group study.

Authors
C Coltman, Jr;S Dahlberg;L Fuller;E Frei
Journal / Conference
ASCO 8:252(#981)
Year
1989
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-781